Delisting risk
N2OFF
Develops mitochondrial transporter drug candidates and European solar and storage projects.
$1.78
After-hours close−0.06 (−3.26%)
At close$1.84(−3.66%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | — | −$25.96 | — |
| May 2026 | — | −$12.10 | — |
| Nov 2025 | — | −$8.29 | — |
| Nov 2024 | — | −$12.91 | — |
The latest year is open to everyone — the 5 quarters behind it read with an account. Sign in | |||
| Aug 2024 | |||
| May 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| Aug 2022 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Aug 13, 2026 | — | −$25.96 | — | — | — | — |
| May 14, 2026 | — | −$12.10 | — | — | — | — |
| Nov 13, 2025 | — | −$8.29 | — | — | $2.0K | — |
| Nov 14, 2024 | — | −$12.91 | — | — | $9.0K | — |
The latest year is open to everyone — the 5 quarters behind it read with an account. Sign in | ||||||
| Aug 14, 2024 | ||||||
| May 15, 2024 | ||||||
| Nov 14, 2023 | ||||||
| Aug 14, 2023 | ||||||
| Aug 15, 2022 | ||||||